Clinical Study of Ligustrazine in Treating Alcohol Addiction

PHASE4RecruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

July 28, 2023

Primary Completion Date

July 31, 2024

Study Completion Date

July 31, 2024

Conditions
Alcohol AbuseArteriosclerosis
Interventions
DRUG

Ligustrazine by intravenously administration

Ligustrazine hydrochloride was administered intravenously by dissolving 40mg in 250ml saline per day for 15 days

DRUG

Ligustrazine by mouth

50 mg Ligustrazine tablet by mouth would be maintained for 1 year

DRUG

Placebo by intravenously administration

Intravenous administration of 250ml saline per day for 15 days

DRUG

Placebo by mouth

50 mg placebo tablet by mouth would be maintained for 1 year

Trial Locations (1)

518118

RECRUITING

Shenzhen Kangning Hospital, Shenzhen

All Listed Sponsors
lead

Shenzhen Kangning Hospital

OTHER